KYNTRA BIO, INC. vs Aardvark Therapeutics, Inc., risk disclosures compared

4topics both disclose

6only KYNTRA BIO, INC.

2only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	KYNTRA BIO, INC.	Aardvark Therapeutics, Inc.
Business Continuity	22	7
Ransomware	15	4
Cross Border Data Transfer	1	3
ESG Reporting	1	1

Only KYNTRA BIO, INC.

Topic	Filings
Restatement	3
Third Party Risk Management	3
Regulatory Reporting	2
Enforcement Action	1
Internal Control	1
Supply Chain Due Diligence	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Data Residency	3
Audit Committee Oversight	2

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

KYNTRA BIO, INC. · Aardvark Therapeutics, Inc. · All companies